Thank you to our speakers, sponsors, and delegates who joined us in July for the summit! If you are interested in the 2024 event, please get in touch at

Fusion Protein Engineering & Developability Summit

Design & Engineer Functional & Manufacturable Novel Fusion Proteins

Your End-to-End Engineering Guide to Balance Immunogenicity, Target Specificity & Functionality for Next Gen Cytokine, Ligand, Enzyme & Bispecific Fusion Proteins

Are you armed with practical, effective engineering strategies to accelerate your fusion protein pipeline into the clinic?

With a flood of recent investments bolstering the therapeutic potential of fusion proteins, now is the time to explore the cutting-edge of engineering and developability advances that have unlocked enhanced therapeutic efficacy.

The Fusion Protein Engineering & Developability Summit was the premium forum of 2023 to gain practical insights from trailblazing biopharma leaders at the forefront of this momentum.


In 2023 there were:

  • 3 days of content packed with 15+ case studies
  • 3 deep-dive workshops into the critical challenges of fusion protein engineering: immunogenicity, machine learning, and target specificity
  • 8+ hours of networking with 60+ protein engineers and developability scientists, including a complementary drinks reception

A Snapshot of the Engaging Sessions in 2023:


On engineering novel antibody fusion proteins for cancer immunotherapy

Screenshot 2023-03-16 163009

On different approaches to identify and engineer out fusion proteins; immunogenicity and toxicity whilst maintaining potency

Toronto Uni
Screenshot 2023-03-17 100901

On developing machine learning tools to improve computational predictions and aid engineering and development strategies

Screenshot 2023-03-16 134317

On complementary assay design to validate engineering strategies to accelerate the route to market

BMS Logo
Asher Bio

On advancing predictions and modifications for the behaviour of fusion proteins for manufacturing and in vivo applications

Untitled design (3)


Our 2023 SnapShot

34751 - Logos
Screenshot 2023-03-17 095041